Zimmer Biomet Holdings Inc (ZBH)

NYSE
Currency in USD
Disclaimer
114.17
+0.25(+0.22%)
Real-time Data
Day's Range
113.59114.36
52 wk Range
102.00149.25
Prev. Close
113.92
Open
113.59
Day's Range
113.59-114.36
52 wk Range
102-149.25
Volume
35,559
Average Vol. (3m)
1,738,063
1-Year Change
-4.26%
Shares Outstanding
208,980,711
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
131.82
Upside +15.46%

People Also Watch

75.27
IFF
+0.05%
125.67
DHI
-1.25%
89.84
SWK
-0.89%
125.29
EL
-0.25%
229.16
ADP
0.00%
How do you feel today about ZBH?
Vote to see community's results!
or

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.